SCHEMBL819986

SCHEMBL819986

CC(=CCCCOc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
KCNA3 P22001 1/20 0.48
RECQL P46063 2/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4828682 0.95 KCNA3 (0.52) L3MBTL1MTNR1AMTNR1BTDP1KCNA3
SCHEMBL17556062 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL17556084 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL17555973 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL17555968 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL17556033 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL17556007 0.94 L3MBTL1 (0.50) L3MBTL1MTNR1AMTNR1BKCNA3RECQL
SCHEMBL196481 0.92 MTNR1A (0.51) L3MBTL1MTNR1AMTNR1BTDP1KCNA3
SCHEMBL15256 0.92 MTNR1A (0.51) L3MBTL1MTNR1AMTNR1BTDP1KCNA3
SCHEMBL7738227 0.88 L3MBTL1 (0.48) L3MBTL1MTNR1AMTNR1BTDP1KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061864-B1 ONE COMPONENT (1K) ANAEROBIC CURABLE COMPOSITION HENKEL AG & CO KGAA (DE) 2023-10-18 EP claimed
US-8372492-B2 crosslinked copolymer of butyl acrylate and phenoxyethyl acrylate; prevent liquid crystal display unevenness in a peripheral portion of a display screen; durability, nonsettling, no defects NITTO DENKO CORPORATION (JP) 2013-02-12 US claimed
US-7744998-B2 Plasticizer-resistant pressure-sensitive adhesive composition and adhesive article 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-06-29 US claimed
EP-1395636-B1 PLASTICIZER-RESISTANT PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND ADHESIVE ARTICLE 3M INNOVATIVE PROPERTIES CO (US) 2008-12-17 EP claimed
JP-61107244-A None JP disclosed
US-20240103199-A1 WINDOW AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-03-28 US disclosed
EP-4297884-A1 CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS 3M Innovative Properties Company (US) 2024-01-03 EP disclosed
US-20230357488-A1 CURABLE RESIN COMPOSITION CANON KK (JP) 2023-11-09 US disclosed
US-11646428-B2 Photocurable resin composition, fuel cell, and sealing method THREEBOND CO., LTD. (JP) 2023-05-09 US disclosed
US-20210399316-A1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD THREEBOND CO., LTD. (JP) 2021-12-23 US disclosed
EP-3926721-A1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD ThreeBond Co., Ltd. (JP) 2021-12-22 EP disclosed
EP-3517571-A1 (METH)ACRYLIC COPOLYMER, RESIN COMPOSITION, MOLDED BODY OF SAME, AND METHOD FOR PRODUCING MOLDED BODY Mitsubishi Gas Chemical Company, Inc. (JP) 2019-07-31 EP disclosed
US-7375150-B2 Thermo stability, is free from the problem of bleeding-out, exhibits its effect independently of humidity, has immediate effectiveness; electrical resistance SANKO CHEMICAL INDUSTRY CO., LTD. (JP) 2008-05-20 US disclosed
US-20070298965-A1 Formulation for Seed Treatment Comprising Polymeric Stickers BASF AKTIENGESELLSCHAFT (DE) 2007-12-27 US disclosed
US-20070225466-A1 Curable organometallic composition, organometallic polymer material and optical component SANYO ELECTRIC CO., LTD. (JP) 2007-09-27 US disclosed
US-20070031758-A1 Positive-type radiation-sensitive resin composition for producing a metal-plating formed material, transcription film and production method of a metal-plating formed material JSR CORPORATION (JP) 2007-02-08 US disclosed
EP-1720407-A1 FORMULATION FOR SEED TREATMENT COMPRISING POLYMERIC STICKERS BASF AKTIENGESELLSCHAFT (DE) 2006-11-15 EP disclosed
WO-2005077170-A1 FORMULATION FOR SEED TREATMENT COMPRISING POLYMERIC STICKERS BASF AKTIENGESELLSCHAFT (DE) 2005-08-25 WO disclosed
US-20040175573-A1 Anti-static composition and method for production thereof SANKO CHEMICAL INDUSTRY CO., LTD. (JP) 2004-09-09 US disclosed
JP-S61107244-A ULTRAVIOLET CURABLE PATTERN FORMING COMPOSITION MITSUI TOATSU CHEM INC 1986-05-26 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070298965-A1 Formulation for Seed Treatment Comprising Polymeric Stickers PFAS, PGLS, AGL L3MBTL1 532/4885MTNR1A 4352/4885MTNR1B 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.